Analyst Ratings for Teva Pharma (TEVA) [Sells]

TEVA Rating Summary

TEVA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on TEVA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $64.09 (+10.5%) * Over Last 12-Mos
Rating Score: 5.8 / 10
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
7/30/2013 Goldman Sachs
» Updated 10/30/2013
Downgrade Sell
(Neutral)
40.00
(N/A)
39.90 58.00 45.36% Details
Like TEVA Ratings? Also take a look at MYL, ACT, BMY, PFE

TEVA Ratings News